...
首页> 外文期刊>Scientific reports. >Copper depletion inhibits CoCl2-induced aggressive phenotype of MCF-7 cells via downregulation of HIF-1 and inhibition of Snail/Twist-mediated epithelial-mesenchymal transition
【24h】

Copper depletion inhibits CoCl2-induced aggressive phenotype of MCF-7 cells via downregulation of HIF-1 and inhibition of Snail/Twist-mediated epithelial-mesenchymal transition

机译:铜耗竭通过下调HIF-1和抑制Snail / Twist介导的上皮-间质转化抑制CoCl 2 诱导的MCF-7细胞的侵袭性表型

获取原文

摘要

Copper, a strictly regulated trace element, is essential for many physiological processes including angiogenesis. Dysregulated angiogenesis has been associated with increased copper in tumors, and thus copper chelators have been used to inhibit tumor angiogenesis. However, it remains unclear whether copper has any effect on epithelial-mesenchymal transition (EMT). Using CoCl2-induced EMT of human breast carcinoma MCF-7 cells, we found that TEPA, a copper chelator, inhibited EMT-like cell morphology and cytoskeleton arrangement triggered by CoCl2; decreased the expression of vimentin and fibronectin, markers typical of EMT; inhibited HIF-1 activation and HIF1-α accumulation in nuclear; and down-regulated the expression of hypoxia-associated transcription factors, Snail and Twist1. Moreover, knockdown copper transport protein, Ctr1 , also inhibited CoCl2-induced EMT and reversed the mesenchymal phenotype. In EMT6 xenograft mouse models, TEPA administration inhibited the tumor growth and increased mice survival. Immunohistochemical analysis of the xenograft further demonstrated that TEPA administration significantly inhibited tumor angiogenesis, down-regulated hypoxia-induced transcription factors, Snail and Twist1, leading to decreased transactivation of EMT-associated marker genes, vimentin and fibronectin. These results indicate that TEPA inhibits CoCl2-induced EMT most likely via HIF1-α-Snail/Twist signaling pathway, and copper depletion may be exploited as a therapeutic for breast cancer.
机译:铜是一种严格调节的微量元素,对于包括血管生成在内的许多生理过程至关重要。血管生成失调与肿瘤中铜的增加有关,因此铜螯合剂已被用于抑制肿瘤血管生成。然而,尚不清楚铜是否对上皮-间质转化(EMT)有影响。使用CoCl 2 诱导的人乳腺癌MCF-7细胞EMT,我们发现铜螯合剂TEPA抑制了由CoCl 2 ;降低EMT典型标志物波形蛋白和纤连蛋白的表达;抑制核中HIF-1的活化和HIF1-α的积累;并下调缺氧相关转录因子Snail和Twist1的表达。而且,敲低的铜转运蛋白Ctr1也抑制了CoCl 2 诱导的EMT并逆转了间充质表型。在EMT6异种移植小鼠模型中,TEPA给药可抑制肿瘤生长并提高小鼠存活率。异种移植物的免疫组织化学分析进一步表明,施用TEPA可以显着抑制肿瘤血管生成,下调缺氧诱导的转录因子Snail和Twist1,从而导致EMT相关标记基因,波形蛋白和纤连蛋白的反式激活减少。这些结果表明,TEPA最有可能通过HIF1-α-Snail/ Twist信号转导途径抑制CoCl 2 诱导的EMT,并且铜耗竭可被用作乳腺癌的治疗剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号